Physician_Profile_ID,Category,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID,Total_Amount_of_Payment_USDollars,Date_of_Payment,Category,Record_ID
85284,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,40.74,02/05/2015,GNRL,260029856
85284,GNRL,"Mylan Specialty L.P.",WV,100000005573,34.84,10/11/2013,GNRL,102243758
85284,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,25.50,07/24/2015,GNRL,290512434
85284,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,20.29,10/23/2014,GNRL,188807996
85284,GNRL,"Sunovion Pharmaceuticals Inc.",MA,100000000254,20.05,05/09/2014,GNRL,163243914
85284,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,19.93,08/04/2014,GNRL,188743638
85284,GNRL,"Sunovion Pharmaceuticals Inc.",MA,100000000254,19.18,12/09/2015,GNRL,321419128
85284,GNRL,"Meda Pharmaceuticals, Inc.",NJ,100000011184,18.70,01/31/2014,GNRL,221136836
85284,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,18.66,10/08/2014,GNRL,202778104
85284,GNRL,"Sunovion Pharmaceuticals Inc.",MA,100000000254,18.57,06/03/2015,GNRL,321432284
85284,GNRL,"Sunovion Pharmaceuticals Inc.",MA,100000000254,17.78,04/13/2015,GNRL,321453183
85284,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,17.15,01/15/2015,GNRL,260127390
85284,GNRL,"Sunovion Pharmaceuticals Inc.",MA,100000000254,17.05,09/23/2013,GNRL,12897413
85284,GNRL,"Meda Pharmaceuticals, Inc.",NJ,100000011184,17.04,10/31/2014,GNRL,221174100
85284,GNRL,"Sunovion Pharmaceuticals Inc.",MA,100000000254,16.91,11/15/2013,GNRL,12897411
85284,GNRL,"Sunovion Pharmaceuticals Inc.",MA,100000000254,16.86,08/20/2015,GNRL,321477454
85284,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,16.51,11/13/2013,GNRL,12247437
85284,GNRL,"Meda Pharmaceuticals, Inc.",NJ,100000011184,16.42,04/16/2014,GNRL,221145772
85284,GNRL,"Meda Pharmaceuticals, Inc.",NJ,100000011184,15.71,09/16/2015,GNRL,326842014
85284,GNRL,"Mylan Specialty L.P.",WV,100000005573,15.36,10/24/2013,GNRL,102245042
85284,GNRL,"Mylan Specialty L.P.",WV,100000005573,15.10,08/12/2015,GNRL,320290164
85284,GNRL,"Sunovion Pharmaceuticals Inc.",MA,100000000254,15.02,10/15/2014,GNRL,163235034
85284,GNRL,"Sunovion Pharmaceuticals Inc.",MA,100000000254,14.94,01/24/2014,GNRL,163279984
85284,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,14.88,04/25/2014,GNRL,196358120
85284,GNRL,"Sunovion Pharmaceuticals Inc.",MA,100000000254,14.41,01/21/2015,GNRL,321552882
85284,GNRL,"Sunovion Pharmaceuticals Inc.",MA,100000000254,14.31,11/18/2014,GNRL,163219776
85284,GNRL,"Sunovion Pharmaceuticals Inc.",MA,100000000254,14.26,08/28/2013,GNRL,12897409
85284,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,14.21,03/28/2014,GNRL,152404818
85284,GNRL,"Sunovion Pharmaceuticals Inc.",MA,100000000254,14.13,09/04/2014,GNRL,163263818
85284,GNRL,"Mylan Specialty L.P.",WV,100000005573,14.06,08/27/2014,GNRL,186102032
85284,GNRL,"Meda Pharmaceuticals, Inc.",NJ,100000011184,14.02,08/19/2015,GNRL,326840694
85284,GNRL,"Meda Pharmaceuticals, Inc.",NJ,100000011184,13.95,11/22/2013,GNRL,105174280
85284,GNRL,"Teva Pharmaceuticals USA, Inc.",PA,100000000141,13.85,09/26/2014,GNRL,173643486
85284,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,13.81,06/15/2015,GNRL,330598285
85284,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,13.65,11/09/2015,GNRL,260023794
85284,GNRL,"Dyax Corp",MA,100000010665,13.63,02/17/2015,GNRL,331505071
85284,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,13.60,06/30/2014,GNRL,188702628
85284,GNRL,"Sunovion Pharmaceuticals Inc.",MA,100000000254,13.57,10/18/2013,GNRL,12897407
85284,GNRL,"Shire North American Group Inc",MA,100000061292,13.46,07/16/2015,GNRL,300586238
85284,GNRL,"Mylan Specialty L.P.",WV,100000005573,13.33,09/13/2013,GNRL,102241596
85284,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,13.33,08/14/2014,GNRL,202778100
85284,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,13.33,01/08/2015,GNRL,330424837
85284,GNRL,"Meda Pharmaceuticals, Inc.",NJ,100000011184,13.28,09/11/2014,GNRL,221168004
85284,GNRL,"Sunovion Pharmaceuticals Inc.",MA,100000000254,13.27,09/28/2015,GNRL,321587824
85284,GNRL,"Meda Pharmaceuticals, Inc.",NJ,100000011184,13.14,10/23/2015,GNRL,326852650
85284,GNRL,"Sunovion Pharmaceuticals Inc.",MA,100000000254,13.02,12/17/2013,GNRL,12897405
85284,GNRL,"Mylan Specialty L.P.",WV,100000005573,12.90,09/05/2014,GNRL,186100120
85284,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,12.88,08/13/2015,GNRL,319228360
85284,GNRL,"Grifols USA, LLC",CA,100000005420,12.80,04/10/2015,GNRL,330039715
85284,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,12.76,11/18/2015,GNRL,320993786
85284,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,12.74,09/08/2014,GNRL,188791846
85284,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,12.66,09/11/2013,GNRL,171872182
85284,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,12.64,07/29/2015,GNRL,320993776
85284,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,12.59,05/14/2014,GNRL,198367176
85284,GNRL,"Sunovion Pharmaceuticals Inc.",MA,100000000254,12.44,02/24/2014,GNRL,163246700
85284,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,12.44,05/20/2015,GNRL,320993772
85284,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,12.42,10/17/2013,GNRL,14270641
85284,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,12.41,04/02/2015,GNRL,260103876
85284,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,12.31,09/02/2015,GNRL,320993778
85284,GNRL,"Mylan Specialty L.P.",WV,100000005573,12.15,09/25/2013,GNRL,102242006
85284,GNRL,"Mylan Specialty L.P.",WV,100000005573,12.04,12/06/2013,GNRL,102249688
85284,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,12.03,10/30/2014,GNRL,198367156
85284,GNRL,"Mylan Specialty L.P.",WV,100000005573,12.02,11/07/2013,GNRL,102247166
85284,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,11.94,06/10/2015,GNRL,263309892
85284,GNRL,"Meda Pharmaceuticals, Inc.",NJ,100000011184,11.88,09/06/2013,GNRL,105174278
85284,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,11.86,08/28/2013,GNRL,24043661
85284,GNRL,"Shire North American Group Inc",MA,100000061292,11.71,09/09/2015,GNRL,300586250
85284,GNRL,"Meda Pharmaceuticals, Inc.",NJ,100000011184,11.66,04/03/2015,GNRL,326834854
85284,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,11.61,05/11/2015,GNRL,319773872
85284,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,11.57,10/14/2015,GNRL,260094560
85284,GNRL,"Mylan Specialty L.P.",WV,100000005573,11.53,03/26/2014,GNRL,186068470
85284,GNRL,"Teva Pharmaceuticals USA, Inc.",PA,100000000141,11.51,05/18/2015,GNRL,293987270
85284,GNRL,"Mylan Specialty L.P.",WV,100000005573,11.38,01/27/2014,GNRL,186038818
85284,GNRL,"Sunovion Pharmaceuticals Inc.",MA,100000000254,11.35,06/13/2014,GNRL,163271596
85284,GNRL,"Alcon Laboratories Inc",TX,100000005405,11.33,05/22/2014,GNRL,167486306
85284,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,11.26,09/15/2015,GNRL,260083534
85284,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,11.26,09/23/2015,GNRL,260109344
85284,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,11.24,12/04/2013,GNRL,171872180
85284,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,11.20,01/29/2015,GNRL,320993770
85284,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,11.13,05/13/2015,GNRL,330528647
85284,GNRL,"Mylan Specialty L.P.",WV,100000005573,11.10,05/15/2015,GNRL,320243550
85284,GNRL,"Alcon Laboratories Inc",TX,100000005405,11.07,11/20/2014,GNRL,167486308
85284,GNRL,"Mylan Specialty L.P.",WV,100000005573,11.05,10/27/2014,GNRL,186114198
85284,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,11.02,12/08/2014,GNRL,202536802
85284,GNRL,"Teva Pharmaceuticals USA, Inc.",PA,100000000141,11.00,05/15/2015,GNRL,293987278
85284,GNRL,"Shire North American Group Inc",MA,100000061292,10.93,03/12/2015,GNRL,299118156
85284,GNRL,"Sunovion Pharmaceuticals Inc.",MA,100000000254,10.84,04/04/2014,GNRL,163267526
85284,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,10.72,05/21/2015,GNRL,260036000
85284,GNRL,"Alcon Laboratories Inc",TX,100000005405,10.71,03/12/2015,GNRL,315023827
85284,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,10.68,09/17/2013,GNRL,12271219
85284,GNRL,"Teva Pharmaceuticals USA, Inc.",PA,100000000141,10.68,01/26/2015,GNRL,293987274
85284,GNRL,"Alcon Laboratories Inc",TX,100000005405,10.59,10/25/2013,GNRL,102430652
85284,GNRL,"Mylan Specialty L.P.",WV,100000005573,10.55,02/12/2014,GNRL,186039258
85284,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,10.41,08/13/2014,GNRL,198367169
85284,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,10.30,11/12/2015,GNRL,320993782
85284,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,10.17,08/20/2014,GNRL,201979656
85284,GNRL,"Mylan Specialty L.P.",WV,100000005573,10.11,12/18/2013,GNRL,102248184
85284,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,9.85,05/08/2014,GNRL,201852642
85284,GNRL,"Mylan Specialty L.P.",WV,100000005573,9.42,05/21/2014,GNRL,186077536
85284,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,9.32,02/10/2014,GNRL,201078088
85284,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,9.22,05/23/2014,GNRL,201674656
85284,GNRL,"Mylan Specialty L.P.",WV,100000005573,9.04,08/14/2013,GNRL,102239334
85284,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,9.04,10/20/2014,GNRL,202234264
85284,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,8.72,04/18/2014,GNRL,201514570
85284,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,8.53,04/24/2014,GNRL,201534264
85284,GNRL,"Mylan Specialty L.P.",WV,100000005573,8.03,06/12/2014,GNRL,186078051
85284,GNRL,"Mylan Specialty L.P.",WV,100000005573,8.03,04/15/2014,GNRL,186070894
85284,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,7.72,03/21/2014,GNRL,201391994
85284,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,7.54,09/29/2014,GNRL,202144116
85284,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,7.53,04/28/2014,GNRL,201561356
85284,GNRL,"Mylan Specialty L.P.",WV,100000005573,7.06,05/04/2014,GNRL,186071854
85284,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,6.75,01/29/2014,GNRL,201490368
85284,GNRL,"Mylan Specialty L.P.",WV,100000005573,6.11,02/12/2014,GNRL,186027486
85284,GNRL,"Dyax Corp",MA,100000010665,5.57,07/29/2015,GNRL,331505067
85284,GNRL,"Mylan Specialty L.P.",WV,100000005573,3.41,09/04/2013,GNRL,102240714
85284,GNRL,"Mylan Specialty L.P.",WV,100000005573,3.25,08/28/2013,GNRL,102237698
85284,GNRL,"Mylan Specialty L.P.",WV,100000005573,3.25,08/14/2013,GNRL,102237422
85284,GNRL,"Mylan Specialty L.P.",WV,100000005573,3.25,10/17/2013,GNRL,102237442
85284,GNRL,"Sunovion Pharmaceuticals Inc.",MA,100000000254,2.99,06/03/2015,GNRL,321776332
